risk factor

Obesity medications linked to reduced chance of MS in real world

The use of obesity medications ā€” approved drugs for treating diabetes and promoting weight loss ā€” is associated with a reduced chance of developing multiple sclerosis (MS), according to real-world data from the U.S. Food and Drug Administration (FDA), a study found. In particular, medicines that activate a receptor…

Higher COVID-19 Risk Tied to 2 MS Therapies, Even With Vaccination

Fully vaccinated multiple sclerosis (MS) patients who are treated with Ocrevus (ocrelizumab) or Gilenya (fingolimod) have a significantly higher risk of COVID-19 infection than those given other immunosuppressive therapies, according to a study in Italy. Called breakthrough infections, these post-vaccination cases of SARS-CoV-2 ā€” the virus that causes…

T. Gondii Parasite May Protect Against Developing MS

Toxoplasmosis, an infection by the parasiteĀ Toxoplasma gondii,Ā has a protective effect against the development of multiple sclerosisĀ (MS), according to a review study. Specifically, people who had been infected with the parasite were 32% less likely to develop MS than those who never had toxoplasmosis. While these findings support T. gondii…